Carcinoma Non-small-cell Lung
📧 Sign up to get email alerts when something new happens for Carcinoma Non-small-cell Lung.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-21EMA Authorised: Krazati (adagrasib) — Bristol-Myers Squibb Pharma EEIG
Authorised approval of Krazati (adagrasib) for non-small cell lung carcinoma by EMA, issued to Bristol-Myers Squibb Pharma EEIG with conditi…
-
EMA approval · 2026-08-18EMA Authorised: Alimta (pemetrexed) — Eli Lilly Nederland B.V.
European Medicines Agency authorises Alimta (pemetrexed) for mesothelioma and non-small-cell lung carcinoma.
-
EMA approval · 2026-08-06EMA Authorised: Docetaxel Kabi (docetaxel) — Fresenius Kabi Deutschland GmbH
EU authorization of Docetaxel Kabi (docetaxel) for multiple cancer indications including head and neck neoplasms, non-small cell lung carcin…
-
EMA approval · 2026-07-13EMA Authorised: Hetronifly (serplulimab) — Accord Healthcare S.L.U.
European Medicines Agency authorises Hetronifly (serplulimab) for multiple indications including small cell lung cancer, non-small cell lung…
-
EMA approval · 2026-07-07EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited
EMA authorises a biosimilar version of bevacizumab (Abevmy) for multiple cancer indications, expanding access to this biologic therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-07-01EMA Authorised: Hetronifly (serplulimab) — Accord Healthcare S.L.U.
European Medicines Agency authorises Hetronifly (serplulimab) for multiple indications including small cell lung cancer, non-small cell lung…
-
EMA approval · 2026-06-24EMA Authorised: Yervoy (Ipilimumab) — Bristol-Myers Squibb Pharma EEIG
Authorised approval for Yervoy (ipilimumab) with multiple indications including melanoma and various carcinomas and mesothelioma; decision d…
-
EMA approval · 2017-11-30EMA Refused: Adlumiz (anamorelin hydrochloride) — Helsinn Birex Pharmaceuticals Ltd.
EMA refused Adlumiz (anamorelin hydrochloride) from Helsinn Birex Pharmaceuticals Ltd., a decision affecting its use for cachexia/anorexia i…